280 related articles for article (PubMed ID: 17470540)
1. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine.
Cerca N; Jefferson KK; Maira-Litrán T; Pier DB; Kelly-Quintos C; Goldmann DA; Azeredo J; Pier GB
Infect Immun; 2007 Jul; 75(7):3406-13. PubMed ID: 17470540
[TBL] [Abstract][Full Text] [Related]
2. The role of epitope specificity in the human opsonic antibody response to the staphylococcal surface polysaccharide poly N-acetyl glucosamine.
Kelly-Quintos C; Kropec A; Briggs S; Ordonez CL; Goldmann DA; Pier GB
J Infect Dis; 2005 Dec; 192(11):2012-9. PubMed ID: 16267775
[TBL] [Abstract][Full Text] [Related]
3. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine.
Maira-Litrán T; Kropec A; Goldmann DA; Pier GB
Infect Immun; 2005 Oct; 73(10):6752-62. PubMed ID: 16177353
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
5. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection.
Kropec A; Maira-Litran T; Jefferson KK; Grout M; Cramton SE; Götz F; Goldmann DA; Pier GB
Infect Immun; 2005 Oct; 73(10):6868-76. PubMed ID: 16177366
[TBL] [Abstract][Full Text] [Related]
6. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.
Skurnik D; Merighi M; Grout M; Gadjeva M; Maira-Litran T; Ericsson M; Goldmann DA; Huang SS; Datta R; Lee JC; Pier GB
J Clin Invest; 2010 Sep; 120(9):3220-33. PubMed ID: 20739753
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
Kelly-Quintos C; Cavacini LA; Posner MR; Goldmann D; Pier GB
Infect Immun; 2006 May; 74(5):2742-50. PubMed ID: 16622211
[TBL] [Abstract][Full Text] [Related]
8. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
Cerca N; Maira-Litrán T; Jefferson KK; Grout M; Goldmann DA; Pier GB
Proc Natl Acad Sci U S A; 2007 May; 104(18):7528-33. PubMed ID: 17446272
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-
Soliman C; Walduck AK; Yuriev E; Richards JS; Cywes-Bentley C; Pier GB; Ramsland PA
J Biol Chem; 2018 Apr; 293(14):5079-5089. PubMed ID: 29449370
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects.
Arciola CR; Campoccia D; Ravaioli S; Montanaro L
Front Cell Infect Microbiol; 2015; 5():7. PubMed ID: 25713785
[TBL] [Abstract][Full Text] [Related]
11. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state.
Cerca N; Jefferson KK; Oliveira R; Pier GB; Azeredo J
Infect Immun; 2006 Aug; 74(8):4849-55. PubMed ID: 16861673
[TBL] [Abstract][Full Text] [Related]
12. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.
Cywes-Bentley C; Skurnik D; Zaidi T; Roux D; Deoliveira RB; Garrett WS; Lu X; O'Malley J; Kinzel K; Zaidi T; Rey A; Perrin C; Fichorova RN; Kayatani AK; Maira-Litràn T; Gening ML; Tsvetkov YE; Nifantiev NE; Bakaletz LO; Pelton SI; Golenbock DT; Pier GB
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2209-18. PubMed ID: 23716675
[TBL] [Abstract][Full Text] [Related]
13. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
[TBL] [Abstract][Full Text] [Related]
14. σ
Valle J; Echeverz M; Lasa I
J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30858304
[No Abstract] [Full Text] [Related]
15. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens.
Gening ML; Maira-Litrán T; Kropec A; Skurnik D; Grout M; Tsvetkov YE; Nifantiev NE; Pier GB
Infect Immun; 2010 Feb; 78(2):764-72. PubMed ID: 19948836
[TBL] [Abstract][Full Text] [Related]
16. Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus.
Brooks JL; Jefferson KK
PLoS Pathog; 2014 Jul; 10(7):e1004292. PubMed ID: 25077798
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of Staphylococcus epidermidis IcaB, a de-N-acetylase important for biofilm formation.
Pokrovskaya V; Poloczek J; Little DJ; Griffiths H; Howell PL; Nitz M
Biochemistry; 2013 Aug; 52(32):5463-71. PubMed ID: 23866051
[TBL] [Abstract][Full Text] [Related]
18. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.
Frank KL; Patel R
Infect Immun; 2007 Oct; 75(10):4728-42. PubMed ID: 17635864
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.
Maira-Litrán T; Kropec A; Abeygunawardana C; Joyce J; Mark G; Goldmann DA; Pier GB
Infect Immun; 2002 Aug; 70(8):4433-40. PubMed ID: 12117954
[TBL] [Abstract][Full Text] [Related]
20. Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
Stevenson TC; Cywes-Bentley C; Moeller TD; Weyant KB; Putnam D; Chang YF; Jones BD; Pier GB; DeLisa MP
Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3106-E3115. PubMed ID: 29555731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]